ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.0 |
| Other income | 0.3 | 0.0 | 0.0 |
| Total income | 0.3 | 0.0 | 0.1 |
| Profit before exceptional items & tax | -0.0 | -0.0 | -0.2 |
| Profit before tax | -0.0 | -0.0 | -0.2 |
| Net profit | -0.0 | -0.1 | -0.2 |
| Operating margin | 0.0% | 0.0% | -200.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: ORTINGLOBE. Figures extracted from the filing.
Ortin Global Ltd: key numbers
- Share price
- ₹13.60
- Market cap
- ₹11.06 Cr
- Revenue (annual)
- ₹0.10 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -16.5×Sector 43.8×
- Promoter holding
- 1.24%+0.01% QoQ
- FII holding
- 0.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ortin Global Ltd
All →Ortin Global Management Change
Ortin Global's auditor M/s. Mathesh & Ramana resigned effective 12 Nov 2026, citing other professional commitments. S. D. Mehta and Co. was appointed as replacement.
Ortin Global Q2 FY27 Results: Net Loss of ₹0.3 Cr, Loss Narrows
Ortin Global Ltd reported a net loss of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.3 Cr
Ortin Global Board Meeting Date
Ortin Global scheduled a board meeting on 11 November 2026 to approve unaudited quarterly results. The trading window stays closed until results are declared.
Ortin Global Other Announcement
Ortin Global filed its quarterly shareholding pattern for the quarter ended 30-Sep-2026 under Regulation 31(1)(b). It is a periodic disclosure with no transaction or money event.
Ortin Global Other Announcement
Ortin Global Ltd has filed the Regulation 74(5) compliance certificate from its RTA for the quarter ended September 30, 2026.
Ortin Global Annual General Meeting
Ortin Global Limited held its 39th Annual General Meeting on September 30, 2026, to discuss financial statements and director-related appointments.